Ovid Therapeutics
OVID
OVID
45 hedge funds and large institutions have $81.8M invested in Ovid Therapeutics in 2017 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.3M |
| 2 |
BlackRock
New York
|
+$11.8M |
| 3 |
Jennison Associates
New York
|
+$6.74M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$5.23M |
| 5 |
O
OppenheimerFunds
New York
|
+$4.46M |
Top Sellers
No sellers this quarter
